Zhuhai Sailong Pharmaceutical Co Ltd Total Liabilities
Zhuhai Sailong Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Zhuhai Sailong Pharmaceutical Co Ltd (002898) has total liabilities worth CN¥477.34 Million CNY (≈ $69.85 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 002898 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)
Total liabilities of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025. This chart illustrates how Zhuhai Sailong Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Zhuhai Sailong Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhuhai Sailong Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Adaptimmune Therapeutics Plc
NASDAQ:ADAP
|
USA | $201.59 Million |
|
Kim Hin Joo
KLSE:0210
|
Malaysia | RM23.55 Million |
|
Clean & Science co. Ltd
KQ:045520
|
Korea | ₩54.59 Billion |
|
Agrimin Ltd
AU:AMN
|
Australia | AU$11.41 Million |
|
Pan Entertainment Co. Ltd
KQ:068050
|
Korea | ₩50.32 Billion |
|
RS Public Company Limited
BK:RS
|
Thailand | ฿5.24 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $1.60 Million |
|
Investcorp Credit Management BDC Inc
NASDAQ:ICMB
|
USA | $111.71 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Zhuhai Sailong Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Zhuhai Sailong Pharmaceutical Co Ltd.
Liquidity & Leverage Metrics
Zhuhai Sailong Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Zhuhai Sailong Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhuhai Sailong Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)
The table below shows the annual total liabilities of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥447.95 Million ≈ $65.55 Million |
+44.99% |
| 2024-12-31 | CN¥308.95 Million ≈ $45.21 Million |
+11.15% |
| 2023-12-31 | CN¥277.96 Million ≈ $40.67 Million |
-13.58% |
| 2022-12-31 | CN¥321.64 Million ≈ $47.07 Million |
+0.79% |
| 2021-12-31 | CN¥319.12 Million ≈ $46.70 Million |
+40.61% |
| 2020-12-31 | CN¥226.96 Million ≈ $33.21 Million |
+28.26% |
| 2019-12-31 | CN¥176.95 Million ≈ $25.89 Million |
+91.71% |
| 2018-12-31 | CN¥92.30 Million ≈ $13.51 Million |
-4.35% |
| 2017-12-31 | CN¥96.50 Million ≈ $14.12 Million |
+88.43% |
| 2016-12-31 | CN¥51.21 Million ≈ $7.49 Million |
-0.63% |
| 2015-12-31 | CN¥51.53 Million ≈ $7.54 Million |
+5.32% |
| 2014-12-31 | CN¥48.93 Million ≈ $7.16 Million |
-34.27% |
| 2013-12-31 | CN¥74.44 Million ≈ $10.89 Million |
-- |
About Zhuhai Sailong Pharmaceutical Co Ltd
Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pan… Read more